Chemotherapy-induced neutropenia is a major risk factor for infection-related morbidity and mortality and an important dose-limiting toxicity in cancer treatment. The incidence of severe ...

Since then, all patients with hematological ... Toxicity Criteria of National Cancer Institute World Health Organization criteria), and duration of neutropenia. We analyzed the following clinical ...

Background The use of quinolone prophylaxis in high-risk neutropenic patients is considered standard of care but the development of resistance is a concern. Previous studies have focused mainly on ...

Neutropenia in individuals with a congenital defect or patients with cancer who are undergoing chemotherapy is generally treated with granulocyte colony-stimulating factor (G-CSF) to restore ...

Jessica Lane, 31, heard a 'crunch' when trying to fit a car seat but things only got worse from there ...

She was told that she had neutropenia — low levels of ... be that they are not offered the most aggressive cancer treatments. “To keep patients safe, we look at neutrophils, but are we ...

Well, neutropenia is one of the results of chemotherapy and occurs when treatment kills ... That is, certain things that once smelled pleasant no longer did and vice versa. Similarly, cancer patients ...

Among patients with HR+/HER2+ breast cancer, Herceptin and Perjeta plus endocrine therapy proved to be beneficial ... “We did ...

A young mother whose arm broke while fitting a car seat just weeks after giving birth had to have the limb amputated after ...

The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...

AstraZeneca’s supplemental New Drug Application (sNDA) for CALQUENCE® (acalabrutinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with previously ...